Pfizer leans on cost cuts to offset falling revenue
By Bhanvi Satija and Michael Erman (Reuters) -Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations and...
Engine Capital pushes Lyft to explore strategic options, including sale
(Reuters) -Activist investment firm Engine Capital wants Lyft (NASDAQ: LYFT ) to consider strategic alternatives, including a sale, piling more pressu...
Regeneron’s first-quarter results miss on lower Eylea demand
By Mariam Sunny (Reuters) -Regeneron’s first-quarter results missed Wall Street estimates on Tuesday due to stiff competition for its blockbuster drug Eylea, further stoking investor...
